Becton, Dickinson and Company (BDX)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 10:08AM EDT. Market open.
| Previous close | 237.13 |
| Open | 237.67 |
| Bid | 235.56 x 800 |
| Ask | 236.00 x 1000 |
| Day's range | 235.39 - 238.04 |
| 52-week range | 229.40 - 287.32 |
| Volume | |
| Avg. volume | 1,320,917 |
| Market cap | 68.772B |
| Beta (5Y monthly) | 0.47 |
| PE ratio (TTM) | 50.96 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.80 (1.60%) |
| Ex-dividend date | 10 June 2024 |
| 1y target est | N/A |
- Zacks
BD's (BDX) FDA-Approved Test to Offer Wider Testing Access
BD's (BDX) receipt of the FDA's clearance for the use of self-collected vaginal specimens for HPV testing is likely to improve screening access to a wider female population.
- Insider Monkey
11 Best Recession Dividend Stocks To Buy
In this article, we discuss 11 best recession dividend stocks to buy. You can skip our detailed analysis of dividend stocks and their past performance during recessionary periods, and go directly to read 5 Best Recession Dividend Stocks To Buy. Several financial analysts, previously forecasting a recession in the US at the end of 2022, […]
- Simply Wall St.
Results: Becton, Dickinson and Company Beat Earnings Expectations And Analysts Now Have New Forecasts
Becton, Dickinson and Company ( NYSE:BDX ) last week reported its latest quarterly results, which makes it a good time...
© 2024 Yahoo. All rights reserved.